Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shintarou Kanda"'
Autor:
Tomonobu Koizumi, Nobumitsu Kobayashi, Shintarou Kanda, Masanori Yasuo, Keishi Kubo, Kenichi Itou
Publikováno v:
Case Reports in Oncology, Vol 2, Iss 2, Pp 77-83 (2009)
We present here a case of diffuse tracheobronchial wall spread of metastatic breast cancer who was successfully treated with trastuzumab plus vinorelbine chemotherapy. The patient had a left radical mastectomy for breast cancer in March 2000 and deve
Externí odkaz:
https://doaj.org/article/cf5be395b71e4903bc7a69805c183ff3
Autor:
Shintarou Kanda, Keishi Kubo, Masanori Yasuo, Yoshimichi Komatsu, Keisaku Fujimoto, Masayuki Hanaoka
Publikováno v:
Internal Medicine. 49:23-30
Objective The purpose of this study was to clarify the differences in physiological properties of the airways between asthma and COPD using an impulse oscillation system (IOS). Patients and Methods Subjects comprised 95 stable COPD patients, 52 never
Autor:
Masanori Yasuo, Shintarou Kanda, Kenichi Itou, Keishi Kubo, Tomonobu Koizumi, Nobumitsu Kobayashi
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 2, Iss 2, Pp 77-83 (2009)
Case Reports in Oncology, Vol 2, Iss 2, Pp 77-83 (2009)
We present here a case of diffuse tracheobronchial wall spread of metastatic breast cancer who was successfully treated with trastuzumab plus vinorelbine chemotherapy. The patient had a left radical mastectomy for breast cancer in March 2000 and deve
Successful Retreatment With ADOC Chemotherapy in Relapsed Thymic Carcinoma: Experiences in Two Cases
Autor:
Yayoi Nomura, Shintarou Kanda, Tomonobu Koizumi, Toshimichi Horiuchi, Hiroshi Yamamoto, Keishi Kubo, Masayuki Hanaoka, Akihiro Kitaguchi
Publikováno v:
World Journal of Oncology
The optimal second-line chemotherapeutic regimen for thymic carcinoma remains uncertain and predictive factors for the response have not been identified. We encountered two cases of relapsed thymic carcinoma with recurrence 1.5 and 8 years after init
Autor:
Atsuhito Ushiki, Daiju Aoyagi, Keishi Kubo, Tomonobu Koizumi, Nobumitsu Kobayashi, Masanori Yasuo, Shintarou Kanda, Hiroshi Yamamoto, Jun Nakayama
Publikováno v:
Japanese journal of clinical oncology. 39(4)
Somatic epidermal growth factor receptor (EGFR) mutations in exons 19 and 21 have been found in non-small cell lung cancer (NSCLC) and are associated with the therapeutic response to gefitinib in patients with advanced NSCLC. We report a case of pleo